50 [34%], respectively), but this difference did not reach statistical significance.
← all excerpts
The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or Mildly Reduced Ejection Fraction.
1
—
—